Brick & Kyle, Associates - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 126 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Brick & Kyle, Associates ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$3,0000.0%5000.0%0.00%0.0%
Q4 2016$3,000
-40.0%
5000.0%0.00%
-50.0%
Q3 2016$5,0000.0%5000.0%0.00%0.0%
Q2 2016$5,000
+25.0%
5000.0%0.00%
+33.3%
Q1 2016$4,000
+33.3%
5000.0%0.00%0.0%
Q4 2015$3,0000.0%5000.0%0.00%0.0%
Q3 2015$3,0005000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders